For example, in a sub-study of CAMS (Cannabinoids in MS), no evidence for a benefic cannabinoid influence on serum levels of IFN-γ, IL-10, IL-12, or C-reactive protein was found. The gene discussed is IL10; the disease is myeloid sarcoma.